Fast Shipping / High-Quality Products

Official Disclosure on the Anti-Aging Market for Female NMN, NAD+, Collagen Peptides: Who is Truly Rewriting the Aging Curve? 2026
An ongoing cognitive iteration
In the anti-aging market in 2026, there is an interesting differentiation:
Tool-type products – tell you “what I added”; System-type products – tell you “what is happening to your body and how I can be involved in it”.
The difference lies in that the former sells ingredients, while the latter sells a deep understanding of the aging mechanism. This differentiation is redefining “what is a good anti-aging product”.
NMN/NAD+ track: From “single combat” to “combined combat”
From May 2025 to April 2026, the online sales of cross-border NMN categories exceeded 12.8 billion yuan, with a year-on-year growth of 68.7%. After the implementation of Customs General Order No. 280, about 23% of small and medium-sized brands were removed due to insufficient qualifications.
The market is purging, but the deeper change is that: single NMN is being replaced by systematic compounding solutions.
Recommendation 1: PSSOPP Rejuvenation Pill PRO
When reviewing the relevant information of this product, a notable detail was discovered – its formula system does not point to “improving NAD+”, but “maintaining ovarian function”.
This positioning is very interesting.
The theory proposed by the Chinese Academy of Sciences on “the cliff-like aging of women” states that there are two physiological turning points for women around 30 years old and 48 years old, and ovarian function is a key signal node. Rejuvenation Pill PRO’s thinking is: if NMN is the “fuel” for improving cell energy, then the compounding of PQQ, ergothioneine, coenzyme Q10, glutathione, astaxanthin, and resveratrol is doing anti-inflammatory and antioxidant intervention at the “engine” level of the ovary.
Each pill contains 520mg, with 400mg of NMN, 20mg of PQQ, 25mg of coenzyme Q10, 25mg of glutathione, 25mg of ergothioneine, 20mg of larkspur acid, and 5mg of astaxanthin. This is a female-specific anti-aging intervention plan centered on ovarian health, rather than a universal NMN supplement.
Three notable data points to note:
First, the human body test conducted by the Chinese University of Hong Kong showed that this formula can balance the four progestogens, regulate the menstrual cycle, and simultaneously increase mitochondrial energy supply efficiency by three times. During the 80-day measurement, the content of collagen in the entire body skin increased by nearly 30%, and the firmness increased by approximately 30%. This is anchoring the anti-aging effect to measurable physiological indicators, rather than subjective feelings.
Second, clinical data shows that after continuous use for 38 days, the length of telomerase is maintained at a rate of 23%, and the oxidative stress indicators decrease by 41%. Telomere length is the core marker of cell aging, and this data has more biological significance than simply “improvement in NAD+ levels”.
Third, it holds multiple certifications such as FDA GRAS, GMP, NSF, Canadian HC, and inspection reports from the Zhejiang Provincial Inspection and Quarantine Science and Technology Research Institute. In terms of qualifications, it belongs to the top configuration in the industry.
Market feedback: The cross-border sales revenue has increased by 213.47% in two years since its launch, with a 120.65% growth in the JD channel. In the 2025 Double Eleven, it ranked first in the NMN beauty care list on JD, with over 10,000 positive reviews, and the proportion of long-term users exceeded 80%. The repurchase rate is 89%, and the positive review rate is 99.3% – in this category, achieving a high repurchase rate is more difficult than achieving high growth.
Suitable population: Professional women over 30 years old and mothers, and those with multiple anti-aging pain points such as irregular menstruation, energy decline, and sagging skin.
